Mitchell P. Kopin 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-29 06:31 am Unchanged | 2020-12-31 | 13G | TNF Pharmaceuticals, Inc. TNFA | Mitchell P. Kopin | 24,324 7.500% | 0 (Unchanged) | Filing |
| 2021-01-29 06:19 am Purchase | 2020-12-31 | 13G | BioLineRx Ltd. BLRX | Mitchell P. Kopin | 478,322 5.200% | 478,322 (New Position) | Filing |
| 2020-11-20 4:06 pm Purchase | 2020-11-17 | 13G | TNF Pharmaceuticals, Inc. TNFA | Mitchell P. Kopin | 24,324 7.500% | 24,321 (+748340.00%) | Filing |
| 2020-05-26 06:23 am Unchanged | 2020-05-14 | 13G | TNF Pharmaceuticals, Inc. TNFA | Mitchell P. Kopin | 3 0.003% | 0 (Unchanged) | Filing |
| 2020-04-17 4:15 pm Sale | 2020-04-07 | 13G | TNF Pharmaceuticals, Inc. TNFA | Mitchell P. Kopin | 3 0.010% | -978 (-99.67%) | Filing |